Financial Results
SHILPAMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Shilpa Medicare reported strong full-year results with standalone revenue growing 25% to ₹59,703 lakhs and net profit surging 96% to ₹13,297 lakhs. Consolidated revenue rose 20% to ₹153,887 lakhs with net profit jumping over 200% to ₹24,333 lakhs compared to ₹7,830 lakhs last year. EPS on standalone basis improved to ₹6.80 from ₹3.48. Exceptional items turned positive at ₹1,942 lakhs versus a loss of ₹4,574 lakhs in the prior year. The company declared a dividend of ₹0.60 per share. Auditors gave an unmodified (clean) opinion. Key notes include restatement of prior year figures due to a merger and some unaudited foreign subsidiary results included.
The company delivered exceptional profit growth driven by improved operational performance and positive exceptional items. The clean audit opinion and dividend declaration are positive signals for shareholders. However, investors should note the restated prior year figures and reliance on unaudited data for some foreign subsidiaries.